Andrew Byrnes

Dr. Andrew Byrnes


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1995 in Neuroscience
Verified
Journal Article
Closed access
Andrew ByrnesAndrew Byrnes
Andrew Byrnes
JRJ.E. Rusby
J.E. Rusby
MWMatthew Wood
Matthew Wood
HCH.M. Charlton
H.M. Charlton

1 December 2008 in Journal of Virology
Verified
Journal Article
Closed access
ZXZhili Xu
Zhili Xu
JTJie Tian
Jie Tian
JSJeffrey S. Smith
Jeffrey S. Smith
Andrew ByrnesAndrew Byrnes
Andrew Byrnes
Kupffer cells (KCs) rapidly remove intravenously injected adenovirus (Ad) vectors from the circulation. A better understanding of the mechanisms involved could suggest strategies to improve Ad gene delivery by suppressing or evading KC uptake. We recently showed that clearance of Ad type 5 vectors by KCs does not involve the interaction of Ad with the well-established Ad receptors, namely, integrins or the coxsackievirus and Ad receptor (J. S. Smith, Z. Xu, J. Tian, S. C. Stevenson, and A. P. Byrnes, Hum. Gene Ther. 19:547-554, 2008). In the current study, we systematically quantified the contributions of various receptors and plasma proteins to the clearance of Ad by KCs. We found that scavenger receptors are a predominant mechanism for the clearance of Ad by KCs. In addition, we found that Ad is opsonized by natural immunoglobulin M antibodies and complement and that these opsonins play a contributory role in the clearance of Ad by KCs. We also examined additional mechanisms that have been postulated to be involved in the clearance of Ad, including the binding of Ad to platelets and vitamin K-dependent coagulation factors, but we found that neither of these were required for the clearance of Ad by KCs.

24 March 2013 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
ZXZhili Xu
Zhili Xu
QQQi Qiu
Qi Qiu
JTJie Tian
Jie Tian
JSJeffrey S Smith
Jeffrey S Smith
GCGina M Conenello
Gina M Conenello
Andrew ByrnesAndrew Byrnes
Andrew Byrnes

1 January 2006 in Molecular Therapy
Verified
Journal Article
Open access
EMElanchezhiyan Manickan
Elanchezhiyan Manickan
JSJeffrey S. Smith
Jeffrey S. Smith
JTJie Tian
Jie Tian
TEThomas L. Eggerman
Thomas L. Eggerman
JLJay N. Lozier
Jay N. Lozier
Andrew ByrnesAndrew Byrnes
Andrew Byrnes
When adenovirus vectors are injected intravenously, they are quickly taken up by Kupffer cells in the liver. We report that this causes rapid necrosis of Kupffer cells in mice at doses of 10(11) particles/kg or higher. By 10 min after intravenous vector injection, Kupffer cells were permeable to propidium iodide and trypan blue. This coincided with a sharp rise in serum lactate dehydrogenase. Ultrastructural examination showed degeneration of Kupffer cells, including complete disappearance of chromatin by 1 h. After an initial intravenous injection of vector, dead Kupffer cells were unable to take up a second dose of vector, and hepatic transgene expression from the second dose was augmented. Death of Kupffer cells did not affect serum levels of IL-6 or IL-12. There was no immediate change in the number of Kupffer cells in the liver, but a significant decline was found by 4 h after injection of vector. Interestingly, substantial numbers of vector-containing Kupffer cells were found in pulmonary capillaries, indicating that they had been swept out of the liver. Together these results show that an intravenous injection of adenovirus vector causes synchronous and surprisingly rapid Kupffer cell death.

1 November 1996 in Trends in Neurosciences
Verified
Journal Article
Closed access
MWMatthew Wood
Matthew Wood
HCHarry M. Charlton
Harry M. Charlton
KWKathryn J. Wood
Kathryn J. Wood
KKKoji Kajiwara
Koji Kajiwara
Andrew ByrnesAndrew Byrnes
Andrew Byrnes

15 January 2000 in Journal of Virology
Verified
Journal Article
Closed access
PDF file
Andrew ByrnesAndrew Byrnes
Andrew Byrnes
DGDiane E. Griffin
Diane E. Griffin
Laboratory strains of Sindbis virus must bind to the negatively charged glycosaminoglycan heparan sulfate in order to efficiently infect cultured cells. During infection of mice, however, we have frequently observed the development of large-plaque viral mutants with a reduced ability to bind to heparan sulfate. Sequencing of these mutants revealed changes of positively charged amino acids in putative heparin-binding domains of the E2 glycoprotein. Recombinant viruses were constructed with these changes as single amino acid substitutions in a strain Toto 1101 background. All exhibited decreased binding to heparan sulfate and had larger plaques than Toto 1101. When injected subcutaneously into neonatal mice, large-plaque viruses produced higher-titer viremia and often caused higher mortality. Because circulating heparin-binding proteins are known to be rapidly sequestered by tissue heparan sulfate, we measured the kinetics of viral clearance following intravenous injection. Much of the parental small-plaque Toto 1101 strain of Sindbis virus was cleared from the circulation by the liver within minutes, in contrast to recombinant large-plaque viruses, which had longer circulating half-lives. These findings indicate that a decreased ability to bind to heparan sulfate allows more efficient viral production in vivo, which may in turn lead to increased mortality. Because Sindbis virus is only one of a growing number of viruses from many families which have been shown to bind to heparan sulfate, these results may be generally applicable to the pathogenesis of such viruses.